Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Solusi Tunas Pratama Tbk. (SUPR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Solusi Tunas Pratama Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Solusi Tunas Pratama Tbk. diperdagangkan di Rp43.850 (kapitalisasi pasar 49,88 T). Perbedaan utamanya: Solusi Tunas Pratama Tbk. jauh lebih besar — sekitar 477,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SUPR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 49,88 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Solusi Tunas Pratama Tbk.
PT Solusi Tunas Pratama Tbk (the company) was established based on the Deed No.5 dated Jul 25, 2006 made in presence of Ridjqi Nurdiani, S.H, a Notary in Bekasi. The Company's articles of association has been amended from time to time, the latest amendment regarding the decrease in nominal value of the Company's shares, the change in the Company's name and the change in the Company's status from private company to public company.
Selengkapnya di halaman SUPR →
